- Home
- BANR vs XENE Comparison
BANR vs XENE Comparison
Compare BANR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- XENE
- Stock Information
- Founded
- BANR 1890
- XENE 1996
- Country
- BANR United States
- XENE Canada
- Employees
- BANR N/A
- XENE N/A
- Industry
- BANR Major Banks
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- XENE Health Care
- Exchange
- BANR Nasdaq
- XENE Nasdaq
- Market Cap
- BANR 2.3B
- XENE 2.5B
- IPO Year
- BANR 1995
- XENE 2014
- Fundamental
- Price
- BANR $60.49
- XENE $35.11
- Analyst Decision
- BANR Buy
- XENE Strong Buy
- Analyst Count
- BANR 6
- XENE 8
- Target Price
- BANR $73.80
- XENE $56.38
- AVG Volume (30 Days)
- BANR 273.5K
- XENE 870.9K
- Earning Date
- BANR 04-16-2025
- XENE 05-08-2025
- Dividend Yield
- BANR 3.17%
- XENE N/A
- EPS Growth
- BANR 5.82
- XENE N/A
- EPS
- BANR 5.09
- XENE N/A
- Revenue
- BANR $614,045,000.00
- XENE N/A
- Revenue This Year
- BANR N/A
- XENE N/A
- Revenue Next Year
- BANR $5.69
- XENE $1,553.36
- P/E Ratio
- BANR $11.89
- XENE N/A
- Revenue Growth
- BANR 3.98
- XENE N/A
- 52 Week Low
- BANR $42.00
- XENE $26.74
- 52 Week High
- BANR $78.05
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- BANR 46.98
- XENE 55.88
- Support Level
- BANR $54.82
- XENE $32.35
- Resistance Level
- BANR $60.99
- XENE $34.08
- Average True Range (ATR)
- BANR 3.24
- XENE 2.43
- MACD
- BANR 0.20
- XENE 0.57
- Stochastic Oscillator
- BANR 60.39
- XENE 96.54
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.